Evidence map›Paper›PMID 39907795›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Beyond FAP: ANTXR1 as a novel target for PET imaging and radio-ligand therapy in immuno-oncology?

Romain-David Seban, Irene Buvat, Laurence Champion, Francois-Clement Bidard, Yann Kieffer, Anne Vincent-Salomon, Agathe Peltier, Fatima Mechta-Grigoriou

Abstract readLetter
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Romain-David SebanDepartment of Nuclear Medicine, Institute of Women's Cancer, Institut Curie, 92210, Saint-Cloud, France. romain.seban@gmail.com.ORCID http://orcid.org/0000-0002-2584-5478
Irene BuvatLaboratoire d'Imagerie Translationnelle en Oncologie, Inserm U1288, PSL University, Paris Saclay University, Institute of Women's Cancer, Institut Curie, 91400, Orsay, France.
Laurence ChampionDepartment of Nuclear Medicine, Institute of Women's Cancer, Institut Curie, 92210, Saint-Cloud, France.
Francois-Clement BidardDepartment of Medical Oncology, Institute of Women's Cancer, Institut Curie, 75006, Paris, France.
Yann KiefferStress and Cancer Laboratory, Equipe Labélisée Par La Ligue Nationale Contre Le Cancer, Inserm U1339 - UMR3666 CNRS, PSL Research University, Institute of Women's Cancer, Institut Curie, 26, rue d'Ulm, F-75248, Paris, France.
Anne Vincent-SalomonDepartment of Diagnostic and Theranostic Medicine, Institute of Women's Cancer, Institut Curie, 75006, Paris, France.
Agathe PeltierStress and Cancer Laboratory, Equipe Labélisée Par La Ligue Nationale Contre Le Cancer, Inserm U1339 - UMR3666 CNRS, PSL Research University, Institute of Women's Cancer, Institut Curie, 26, rue d'Ulm, F-75248, Paris, France.
Fatima Mechta-GrigoriouStress and Cancer Laboratory, Equipe Labélisée Par La Ligue Nationale Contre Le Cancer, Inserm U1339 - UMR3666 CNRS, PSL Research University, Institute of Women's Cancer, Institut Curie, 26, rue d'Ulm, F-75248, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39907795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.